ReP USP - Resultado da busca

Trabalho de evento-resumo periodico
Myositis Specific-Autoantibodies: Predictors of Short-Term Good Outcome in Rituximab Treated-Refractory Idiopathic Inflammatory Myopathies (2015)
Souza, Fernando Henrique Carlos de; Miossi, Renata; Moraes, Julio C. B.; Bonfiglioli, Karina; Bonfá, Eloisa; Shinjo, Samuel Katsuyuki
Conference titles: ACR/ARHP Annual Meeting. Unidade: FM
Subjects: INFLAMAÇÃO, AUTOANTICORPOS, MIOSITE, FÁRMACOS IMUNOSSUPRESSORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Fernando Henrique Carlos de et al. Myositis Specific-Autoantibodies: Predictors of Short-Term Good Outcome in Rituximab Treated-Refractory Idiopathic Inflammatory Myopathies. . Atlanta: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://onlinelibrary.wiley.com/doi/10.1002/art.39448/pdf. Acesso em: 02 nov. 2024. , 2015
APA
Souza, F. H. C. de, Miossi, R., Moraes, J. C. B., Bonfiglioli, K., Bonfá, E., & Shinjo, S. K. (2015). Myositis Specific-Autoantibodies: Predictors of Short-Term Good Outcome in Rituximab Treated-Refractory Idiopathic Inflammatory Myopathies. Atlanta: Faculdade de Medicina, Universidade de São Paulo. doi:10.1002/art.39448
NLM
Souza FHC de, Miossi R, Moraes JCB, Bonfiglioli K, Bonfá E, Shinjo SK. Myositis Specific-Autoantibodies: Predictors of Short-Term Good Outcome in Rituximab Treated-Refractory Idiopathic Inflammatory Myopathies [Internet]. 2015 ; 67( S10):[citado 2024 nov. 02 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/art.39448/pdf
Vancouver
Souza FHC de, Miossi R, Moraes JCB, Bonfiglioli K, Bonfá E, Shinjo SK. Myositis Specific-Autoantibodies: Predictors of Short-Term Good Outcome in Rituximab Treated-Refractory Idiopathic Inflammatory Myopathies [Internet]. 2015 ; 67( S10):[citado 2024 nov. 02 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/art.39448/pdf
Trabalho de evento-resumo periodico
Sulfasalazine Comedication: A Predictor of Reduced Long-Term Anti-TNF Switch in Ankylosing Spondylitis (2015)
Shimabuco, Andrea Y.; Gonçalves, Celio R.; Moraes, Julio C. B.; Waisberg, Mariana G.; Sampaio-Barros, Percival D.; Goldenstein-Schainberg, Cláudia; Bonfá, Eloisa; Saad, Carla G. S.
Conference titles: ACR/ARHP Annual Meeting. Unidade: FM
Subjects: TERAPIAS COMPLEMENTARES, FATORES BIOLÓGICOS, ESPONDILITE ANQUILOSANTE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SHIMABUCO, Andrea Y. et al. Sulfasalazine Comedication: A Predictor of Reduced Long-Term Anti-TNF Switch in Ankylosing Spondylitis. . Atlanta: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://onlinelibrary.wiley.com/doi/10.1002/art.39448/pdf. Acesso em: 02 nov. 2024. , 2015
APA
Shimabuco, A. Y., Gonçalves, C. R., Moraes, J. C. B., Waisberg, M. G., Sampaio-Barros, P. D., Goldenstein-Schainberg, C., et al. (2015). Sulfasalazine Comedication: A Predictor of Reduced Long-Term Anti-TNF Switch in Ankylosing Spondylitis. Atlanta: Faculdade de Medicina, Universidade de São Paulo. doi:10.1002/art.39448
NLM
Shimabuco AY, Gonçalves CR, Moraes JCB, Waisberg MG, Sampaio-Barros PD, Goldenstein-Schainberg C, Bonfá E, Saad CGS. Sulfasalazine Comedication: A Predictor of Reduced Long-Term Anti-TNF Switch in Ankylosing Spondylitis [Internet]. 2015 ; 67( S10):[citado 2024 nov. 02 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/art.39448/pdf
Vancouver
Shimabuco AY, Gonçalves CR, Moraes JCB, Waisberg MG, Sampaio-Barros PD, Goldenstein-Schainberg C, Bonfá E, Saad CGS. Sulfasalazine Comedication: A Predictor of Reduced Long-Term Anti-TNF Switch in Ankylosing Spondylitis [Internet]. 2015 ; 67( S10):[citado 2024 nov. 02 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/art.39448/pdf
Trabalho de evento-resumo periodico
Evidence of Serological IL-23/IL-17 Axis Activation in Ankylosing Spondylitis Patients with Long-Term TNF Blockade: The Missing Therapy Target? (2015)
Milanez, Fernanda M.; Saad, Carla G.S.; Moraes, Julio C. B.; Viana, Vilma S. T.; Moraes, Julio C. B.; Périco, Grégory V.; Gonçalves, Celio R.; Bonfá, Eloisa
Conference titles: ACR/ARHP Annual Meeting. Unidade: FM
Subjects: DOENÇAS NEUROMUSCULARES, FATORES BIOLÓGICOS, ESPONDILITE ANQUILOSANTE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MILANEZ, Fernanda M. et al. Evidence of Serological IL-23/IL-17 Axis Activation in Ankylosing Spondylitis Patients with Long-Term TNF Blockade: The Missing Therapy Target?. . Atlanta: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://onlinelibrary.wiley.com/doi/10.1002/art.39448/pdf. Acesso em: 02 nov. 2024. , 2015
APA
Milanez, F. M., Saad, C. G. S., Moraes, J. C. B., Viana, V. S. T., Moraes, J. C. B., Périco, G. V., et al. (2015). Evidence of Serological IL-23/IL-17 Axis Activation in Ankylosing Spondylitis Patients with Long-Term TNF Blockade: The Missing Therapy Target? Atlanta: Faculdade de Medicina, Universidade de São Paulo. doi:10.1002/art.39448
NLM
Milanez FM, Saad CGS, Moraes JCB, Viana VST, Moraes JCB, Périco GV, Gonçalves CR, Bonfá E. Evidence of Serological IL-23/IL-17 Axis Activation in Ankylosing Spondylitis Patients with Long-Term TNF Blockade: The Missing Therapy Target? [Internet]. 2015 ; 67( S10):[citado 2024 nov. 02 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/art.39448/pdf
Vancouver
Milanez FM, Saad CGS, Moraes JCB, Viana VST, Moraes JCB, Périco GV, Gonçalves CR, Bonfá E. Evidence of Serological IL-23/IL-17 Axis Activation in Ankylosing Spondylitis Patients with Long-Term TNF Blockade: The Missing Therapy Target? [Internet]. 2015 ; 67( S10):[citado 2024 nov. 02 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/art.39448/pdf
Trabalho de evento-resumo periodico
Long-Term Evaluation of NT-Probnp Levels in Ankylosing Spondylitis Patients Under TNF Blockers: A Marker of Persistent Disease Activity? (2014)
Russo, Debora; Saad, Carla G. S.; Ribeiro, Ana C. M.; Goldeinstein-Schainberg, Claudia; Sampaio-Barros, Percival D.; Goncalves, Celio R.; Bonfa, Eloisa; Moraes, Julio C. B.
Source: Arthritis and rheumatism. Conference titles: ACR/ARHP Annual Meeting. Unidade: FM
Subjects: ESPONDILITE ANQUILOSANTE, PEPTÍDEOS, BIOMARCADORES, RESUMOS (EVENTOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RUSSO, Debora et al. Long-Term Evaluation of NT-Probnp Levels in Ankylosing Spondylitis Patients Under TNF Blockers: A Marker of Persistent Disease Activity?. Arthritis and rheumatism. Atlanta: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://onlinelibrary.wiley.com/doi/10.1002/art.v66.S10/issuetoc. Acesso em: 02 nov. 2024. , 2014
APA
Russo, D., Saad, C. G. S., Ribeiro, A. C. M., Goldeinstein-Schainberg, C., Sampaio-Barros, P. D., Goncalves, C. R., et al. (2014). Long-Term Evaluation of NT-Probnp Levels in Ankylosing Spondylitis Patients Under TNF Blockers: A Marker of Persistent Disease Activity? Arthritis and rheumatism. Atlanta: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://onlinelibrary.wiley.com/doi/10.1002/art.v66.S10/issuetoc
NLM
Russo D, Saad CGS, Ribeiro ACM, Goldeinstein-Schainberg C, Sampaio-Barros PD, Goncalves CR, Bonfa E, Moraes JCB. Long-Term Evaluation of NT-Probnp Levels in Ankylosing Spondylitis Patients Under TNF Blockers: A Marker of Persistent Disease Activity? [Internet]. Arthritis and rheumatism. 2014 ; 66( S10): S426.[citado 2024 nov. 02 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/art.v66.S10/issuetoc
Vancouver
Russo D, Saad CGS, Ribeiro ACM, Goldeinstein-Schainberg C, Sampaio-Barros PD, Goncalves CR, Bonfa E, Moraes JCB. Long-Term Evaluation of NT-Probnp Levels in Ankylosing Spondylitis Patients Under TNF Blockers: A Marker of Persistent Disease Activity? [Internet]. Arthritis and rheumatism. 2014 ; 66( S10): S426.[citado 2024 nov. 02 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/art.v66.S10/issuetoc
Trabalho de evento-resumo periodico
Abatacept Related Infections: No Association with Gammaglobulin Reduction (2014)
Dinis, Valquiria; Viana, Vilma S. T.; Leon, Elaine P.; Silva, Clovis A; Saad, Carla G. S.; Moraes, Julio C. B.; Bonfa, Eloisa; Ribeiro, Ana C. M.
Source: Arthritis and rheumatism. Conference titles: ACR/ARHP Annual Meeting. Unidade: FM
Subjects: ARTRITE REUMATOIDE, ANTICORPOS, IMUNOGLOBULINAS, RESUMOS (EVENTOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DINIS, Valquiria et al. Abatacept Related Infections: No Association with Gammaglobulin Reduction. Arthritis and rheumatism. Atlanta: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://onlinelibrary.wiley.com/doi/10.1002/art.v66.S10/issuetoc. Acesso em: 02 nov. 2024. , 2014
APA
Dinis, V., Viana, V. S. T., Leon, E. P., Silva, C. A., Saad, C. G. S., Moraes, J. C. B., et al. (2014). Abatacept Related Infections: No Association with Gammaglobulin Reduction. Arthritis and rheumatism. Atlanta: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://onlinelibrary.wiley.com/doi/10.1002/art.v66.S10/issuetoc
NLM
Dinis V, Viana VST, Leon EP, Silva CA, Saad CGS, Moraes JCB, Bonfa E, Ribeiro ACM. Abatacept Related Infections: No Association with Gammaglobulin Reduction [Internet]. Arthritis and rheumatism. 2014 ; 66( S10): S941.[citado 2024 nov. 02 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/art.v66.S10/issuetoc
Vancouver
Dinis V, Viana VST, Leon EP, Silva CA, Saad CGS, Moraes JCB, Bonfa E, Ribeiro ACM. Abatacept Related Infections: No Association with Gammaglobulin Reduction [Internet]. Arthritis and rheumatism. 2014 ; 66( S10): S941.[citado 2024 nov. 02 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/art.v66.S10/issuetoc
Trabalho de evento-resumo periodico
Behçet's discase activity: an important factor for immunogenicity of unadjuvanted influenza A/H1N1 vaccine (2013)
Prado, Leandro L.; Saad, Carla G. S.; Moraes, Julio C. B.; Ribeiro, Ana Cristina Medeiros; Aikawa, Nadia E.; Silva, Clovis Artur Almeida da; Schainberg, Claudia G.; Barros, Percival D.Sampaio; Precioso, Alexander R.; Ishida, Maria Márcia Imenes; Bonfá, Eloísa Silva Dutra de Oliveira; Gonçalves, Celio
Source: Arthristis and rheumatism. Conference titles: 2013 Annual meeting. Unidade: FM
Subjects: SÍNDROME DE BEHCET (IMUNOLOGIA), INFLUENZA, VACINAS VIRAIS, FÁRMACOS IMUNOSSUPRESSORES, RESUMOS (EVENTOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRADO, Leandro L. et al. Behçet's discase activity: an important factor for immunogenicity of unadjuvanted influenza A/H1N1 vaccine. Arthristis and rheumatism. Atlanta: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 02 nov. 2024. , 2013
APA
Prado, L. L., Saad, C. G. S., Moraes, J. C. B., Ribeiro, A. C. M., Aikawa, N. E., Silva, C. A. A. da, et al. (2013). Behçet's discase activity: an important factor for immunogenicity of unadjuvanted influenza A/H1N1 vaccine. Arthristis and rheumatism. Atlanta: Faculdade de Medicina, Universidade de São Paulo.
NLM
Prado LL, Saad CGS, Moraes JCB, Ribeiro ACM, Aikawa NE, Silva CAA da, Schainberg CG, Barros PDS, Precioso AR, Ishida MMI, Bonfá ESD de O, Gonçalves C. Behçet's discase activity: an important factor for immunogenicity of unadjuvanted influenza A/H1N1 vaccine. Arthristis and rheumatism. 2013 ; 65( S10): S744.[citado 2024 nov. 02 ]
Vancouver
Prado LL, Saad CGS, Moraes JCB, Ribeiro ACM, Aikawa NE, Silva CAA da, Schainberg CG, Barros PDS, Precioso AR, Ishida MMI, Bonfá ESD de O, Gonçalves C. Behçet's discase activity: an important factor for immunogenicity of unadjuvanted influenza A/H1N1 vaccine. Arthristis and rheumatism. 2013 ; 65( S10): S744.[citado 2024 nov. 02 ]
Trabalho de evento-resumo periodico
Latent tuberculosis screening and treatment in ankylosing spondylitis patients eligible for anti-TNF therapy in endemic area (2013)
Miossi, Renata; Bonfiglioli, Karina Rossi; Saad,Carla G. S.; Ribeiro Ana Cristina; Moraes, Julio C. B.; Bonfá, Eloísa Silva Dutra de Oliveira
Source: Arthristis and rheumatism. Conference titles: 2013 Annual meeting. Unidade: FM
Subjects: TUBERCULOSE (TERAPIA), ESPONDILITE ANQUILOSANTE, DOENÇAS REUMÁTICAS, RESUMOS (EVENTOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MIOSSI, Renata et al. Latent tuberculosis screening and treatment in ankylosing spondylitis patients eligible for anti-TNF therapy in endemic area. Arthristis and rheumatism. Atlanta: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 02 nov. 2024. , 2013
APA
Miossi, R., Bonfiglioli, K. R., Saad, C. G. S., Ribeiro Ana Cristina,, Moraes, J. C. B., & Bonfá, E. S. D. de O. (2013). Latent tuberculosis screening and treatment in ankylosing spondylitis patients eligible for anti-TNF therapy in endemic area. Arthristis and rheumatism. Atlanta: Faculdade de Medicina, Universidade de São Paulo.
NLM
Miossi R, Bonfiglioli KR, Saad CGS, Ribeiro Ana Cristina, Moraes JCB, Bonfá ESD de O. Latent tuberculosis screening and treatment in ankylosing spondylitis patients eligible for anti-TNF therapy in endemic area. Arthristis and rheumatism. 2013 ; 65( S10): S645.[citado 2024 nov. 02 ]
Vancouver
Miossi R, Bonfiglioli KR, Saad CGS, Ribeiro Ana Cristina, Moraes JCB, Bonfá ESD de O. Latent tuberculosis screening and treatment in ankylosing spondylitis patients eligible for anti-TNF therapy in endemic area. Arthristis and rheumatism. 2013 ; 65( S10): S645.[citado 2024 nov. 02 ]
Trabalho de evento-resumo periodico
Long-term evaluation of cardiac function in juvenile idiopathic arthritis under anti-tumor necrosis factor therapy (2013)
Lianza, Alessandro C.; Aikawa, Nadia E.; Moraes, Julio C. B.; Leal, Gabriela N.; Morthy, Samira S.; Bonfá, Eloísa Silva Dutra de Oliveira; Silva, Clovis Artur Almeida da
Source: Arthristis and rheumatism. Conference titles: 2013 Annual meeting. Unidade: FM
Subjects: ARTRITE REUMATOIDE, BIOMARCADORES, NECROSE, SEGUIMENTOS, ARTRITE (TERAPIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIANZA, Alessandro C. et al. Long-term evaluation of cardiac function in juvenile idiopathic arthritis under anti-tumor necrosis factor therapy. Arthristis and rheumatism. Atlanta: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 02 nov. 2024. , 2013
APA
Lianza, A. C., Aikawa, N. E., Moraes, J. C. B., Leal, G. N., Morthy, S. S., Bonfá, E. S. D. de O., & Silva, C. A. A. da. (2013). Long-term evaluation of cardiac function in juvenile idiopathic arthritis under anti-tumor necrosis factor therapy. Arthristis and rheumatism. Atlanta: Faculdade de Medicina, Universidade de São Paulo.
NLM
Lianza AC, Aikawa NE, Moraes JCB, Leal GN, Morthy SS, Bonfá ESD de O, Silva CAA da. Long-term evaluation of cardiac function in juvenile idiopathic arthritis under anti-tumor necrosis factor therapy. Arthristis and rheumatism. 2013 ; 65( S10): S121.[citado 2024 nov. 02 ]
Vancouver
Lianza AC, Aikawa NE, Moraes JCB, Leal GN, Morthy SS, Bonfá ESD de O, Silva CAA da. Long-term evaluation of cardiac function in juvenile idiopathic arthritis under anti-tumor necrosis factor therapy. Arthristis and rheumatism. 2013 ; 65( S10): S121.[citado 2024 nov. 02 ]
Artigo de periodico
NT-proBNP levels may be influenced by inflammation in active ankylosing spondylitis receiving TNF blockers: a pilot study (2013)
Moraes, Julio C. B.; Ribeiro, Ana C. M.; Saad, Carla G. S.; Lianza, Alessandro C.; Silva, Clovis A.; Bonfá, Eloísa
Source: Clinical rheumatology. Unidade: FM
Subjects: ECOCARDIOGRAFIA, INFLAMAÇÃO, ANQUILOSE, DOENÇAS CARDIOVASCULARES, PEPTÍDEO NATRIURÉTICO ATRIAL, FATORES DE RISCO, ESPONDILITE ANQUILOSANTE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORAES, Julio C. B. et al. NT-proBNP levels may be influenced by inflammation in active ankylosing spondylitis receiving TNF blockers: a pilot study. Clinical rheumatology, v. 32, n. 6, p. 879-883, 2013Tradução . . Disponível em: http://link.springer.com/content/pdf/10.1007%2Fs10067-013-2182-x.pdf. Acesso em: 02 nov. 2024.
APA
Moraes, J. C. B., Ribeiro, A. C. M., Saad, C. G. S., Lianza, A. C., Silva, C. A., & Bonfá, E. (2013). NT-proBNP levels may be influenced by inflammation in active ankylosing spondylitis receiving TNF blockers: a pilot study. Clinical rheumatology, 32( 6), 879-883. doi:10.1007/s10067-013-2182-x
NLM
Moraes JCB, Ribeiro ACM, Saad CGS, Lianza AC, Silva CA, Bonfá E. NT-proBNP levels may be influenced by inflammation in active ankylosing spondylitis receiving TNF blockers: a pilot study [Internet]. Clinical rheumatology. 2013 ; 32( 6): 879-883.[citado 2024 nov. 02 ] Available from: http://link.springer.com/content/pdf/10.1007%2Fs10067-013-2182-x.pdf
Vancouver
Moraes JCB, Ribeiro ACM, Saad CGS, Lianza AC, Silva CA, Bonfá E. NT-proBNP levels may be influenced by inflammation in active ankylosing spondylitis receiving TNF blockers: a pilot study [Internet]. Clinical rheumatology. 2013 ; 32( 6): 879-883.[citado 2024 nov. 02 ] Available from: http://link.springer.com/content/pdf/10.1007%2Fs10067-013-2182-x.pdf
Trabalho de evento-resumo periodico
Fat mass and resistin: predictive factors for Anti-TNF theraphy response in ankylosing spondylitis patients (2013)
Saad, Carla G. S.; Abreu, Andressa Silva; Ribeiro, Ana Cristina Medeiros; Moraes, Julio C. B.; Perandini, Luiz A.; Dassouki, Thalita; Pereira, Rosa Maria Rodrigues; Bonfá, Eloísa Silva Dutra de Oliveira; Pinto, Ana Lucia S.
Source: Arthristis and rheumatism. Conference titles: 2013 Annual meeting. Unidade: FM
Subjects: TECIDO ADIPOSO (IMUNOLOGIA;FISIOPATOLOGIA), INFLAMAÇÃO, ESPONDILITE ANQUILOSANTE, QUALIDADE DE VIDA, RESUMOS (EVENTOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SAAD, Carla G. S. et al. Fat mass and resistin: predictive factors for Anti-TNF theraphy response in ankylosing spondylitis patients. Arthristis and rheumatism. Atlanta: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 02 nov. 2024. , 2013
APA
Saad, C. G. S., Abreu, A. S., Ribeiro, A. C. M., Moraes, J. C. B., Perandini, L. A., Dassouki, T., et al. (2013). Fat mass and resistin: predictive factors for Anti-TNF theraphy response in ankylosing spondylitis patients. Arthristis and rheumatism. Atlanta: Faculdade de Medicina, Universidade de São Paulo.
NLM
Saad CGS, Abreu AS, Ribeiro ACM, Moraes JCB, Perandini LA, Dassouki T, Pereira RMR, Bonfá ESD de O, Pinto ALS. Fat mass and resistin: predictive factors for Anti-TNF theraphy response in ankylosing spondylitis patients. Arthristis and rheumatism. 2013 ; 65( S10): S1058.[citado 2024 nov. 02 ]
Vancouver
Saad CGS, Abreu AS, Ribeiro ACM, Moraes JCB, Perandini LA, Dassouki T, Pereira RMR, Bonfá ESD de O, Pinto ALS. Fat mass and resistin: predictive factors for Anti-TNF theraphy response in ankylosing spondylitis patients. Arthristis and rheumatism. 2013 ; 65( S10): S1058.[citado 2024 nov. 02 ]
Artigo de periodico
High disease activity: An independent factor for reduced immunogenicity of the pandemic influenza a vaccine in patients with juvenile systemic lupus erythematosus (2013)
Campos, Lucia M. A.; Silva, Clovis A.; Aikawwa, Nadia E.; Jesus, Adriana A.; Moraes, Julio C. B.; Miraglia, Joao; Ishida, Maria A.; Bueno, Cleonice; Pereira, Rosa M. R.; Bonfa, Eloisa
Source: Arthritis Care & Research. Unidade: FM
Subjects: INFLUENZA (IMUNOLOGIA), VACINAS VIRAIS (EFEITOS ADVERSOS), REGRESSÃO LOGÍSTICA, IMUNOLOGIA CELULAR, ANTICORPOS (PRODUÇÃO), LÚPUS ERITEMATOSO SISTÊMICO, FEBRE REUMÁTICA (IMUNOLOGIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAMPOS, Lucia M. A. et al. High disease activity: An independent factor for reduced immunogenicity of the pandemic influenza a vaccine in patients with juvenile systemic lupus erythematosus. Arthritis Care & Research, v. 65, n. 7, p. 1121-1127, 2013Tradução . . Disponível em: http://onlinelibrary.wiley.com/doi/10.1002/acr.21948/pdf. Acesso em: 02 nov. 2024.
APA
Campos, L. M. A., Silva, C. A., Aikawwa, N. E., Jesus, A. A., Moraes, J. C. B., Miraglia, J., et al. (2013). High disease activity: An independent factor for reduced immunogenicity of the pandemic influenza a vaccine in patients with juvenile systemic lupus erythematosus. Arthritis Care & Research, 65( 7), 1121-1127. doi:10.1002/acr.21948
NLM
Campos LMA, Silva CA, Aikawwa NE, Jesus AA, Moraes JCB, Miraglia J, Ishida MA, Bueno C, Pereira RMR, Bonfa E. High disease activity: An independent factor for reduced immunogenicity of the pandemic influenza a vaccine in patients with juvenile systemic lupus erythematosus [Internet]. Arthritis Care & Research. 2013 ; 65( 7): 1121-1127.[citado 2024 nov. 02 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/acr.21948/pdf
Vancouver
Campos LMA, Silva CA, Aikawwa NE, Jesus AA, Moraes JCB, Miraglia J, Ishida MA, Bueno C, Pereira RMR, Bonfa E. High disease activity: An independent factor for reduced immunogenicity of the pandemic influenza a vaccine in patients with juvenile systemic lupus erythematosus [Internet]. Arthritis Care & Research. 2013 ; 65( 7): 1121-1127.[citado 2024 nov. 02 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/acr.21948/pdf
Artigo de periodico
Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy? (2012)
Saad, Carla G. S.; Ribeiro, Ana C. M.; Moraes, Julio C. B.; Takayama, Liliam; Goncalves, Celio R.; Rodrigues, Marcelo B.; Oliveira, Ricardo M. de; Silva, Clovis A.; Bonfa, Eloisa; Pereira, Rosa M. R.
Source: Arthritis research & therapy. Unidade: FM
Subjects: NECROSE, BIOMARCADORES, INFLAMAÇÃO (PARÂMETROS), ESPONDILITE ANQUILOSANTE, METALOPROTEINASES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SAAD, Carla G. S. et al. Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy?. Arthritis research & therapy, v. 14, n. 5, p. (online), 2012Tradução . . Disponível em: http://arthritis-research.com/content/pdf/ar4055.pdf. Acesso em: 02 nov. 2024.
APA
Saad, C. G. S., Ribeiro, A. C. M., Moraes, J. C. B., Takayama, L., Goncalves, C. R., Rodrigues, M. B., et al. (2012). Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy? Arthritis research & therapy, 14( 5), (online). doi:10.1186/ar4055
NLM
Saad CGS, Ribeiro ACM, Moraes JCB, Takayama L, Goncalves CR, Rodrigues MB, Oliveira RM de, Silva CA, Bonfa E, Pereira RMR. Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy? [Internet]. Arthritis research & therapy. 2012 ; 14( 5): (online).[citado 2024 nov. 02 ] Available from: http://arthritis-research.com/content/pdf/ar4055.pdf
Vancouver
Saad CGS, Ribeiro ACM, Moraes JCB, Takayama L, Goncalves CR, Rodrigues MB, Oliveira RM de, Silva CA, Bonfa E, Pereira RMR. Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy? [Internet]. Arthritis research & therapy. 2012 ; 14( 5): (online).[citado 2024 nov. 02 ] Available from: http://arthritis-research.com/content/pdf/ar4055.pdf
Artigo de periodico
Influenza A/H1N1 vaccination of patients with SLE: can antimalarial drugs restore diminished response under immunosuppressive therapy? (2012)
Borba, Eduardo F.; Saad, Carla G. S.; Pasoto, Sandra G.; Calich, Ana L. G.; Aikawa, Nadia E.; Ribeiro, Ana C. M.; Moraes, Julio C. B.; Leon, Elaine P.; Costa, Luciana P.; Guedes, Lissiane K. N.; Silva, Clovis A. A.; Goncalves, Celio R.; Fuller, Ricardo; Oliveira, Suzimara A.; Ishida, Maria A.; Precioso, Alexander R.; Bonfa, Eloisa
Source: Rheumatology. Unidade: FM
Subjects: FÁRMACOS IMUNOSSUPRESSORES (USO TERAPÊUTICO), VACINAS VIRAIS (IMUNOLOGIA), INFLUENZA (IMUNOLOGIA), VACINAÇÃO, LÚPUS ERITEMATOSO SISTÊMICO (IMUNOLOGIA), ANTIMALÁRICOS (APLICAÇÕES TERAPÊUTICAS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORBA, Eduardo F. et al. Influenza A/H1N1 vaccination of patients with SLE: can antimalarial drugs restore diminished response under immunosuppressive therapy?. Rheumatology, v. 51, n. 6, p. 1061-1069, 2012Tradução . . Disponível em: https://doi.org/10.1093/rheumatology/ker427. Acesso em: 02 nov. 2024.
APA
Borba, E. F., Saad, C. G. S., Pasoto, S. G., Calich, A. L. G., Aikawa, N. E., Ribeiro, A. C. M., et al. (2012). Influenza A/H1N1 vaccination of patients with SLE: can antimalarial drugs restore diminished response under immunosuppressive therapy? Rheumatology, 51( 6), 1061-1069. doi:10.1093/rheumatology/ker427
NLM
Borba EF, Saad CGS, Pasoto SG, Calich ALG, Aikawa NE, Ribeiro ACM, Moraes JCB, Leon EP, Costa LP, Guedes LKN, Silva CAA, Goncalves CR, Fuller R, Oliveira SA, Ishida MA, Precioso AR, Bonfa E. Influenza A/H1N1 vaccination of patients with SLE: can antimalarial drugs restore diminished response under immunosuppressive therapy? [Internet]. Rheumatology. 2012 ; 51( 6): 1061-1069.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1093/rheumatology/ker427
Vancouver
Borba EF, Saad CGS, Pasoto SG, Calich ALG, Aikawa NE, Ribeiro ACM, Moraes JCB, Leon EP, Costa LP, Guedes LKN, Silva CAA, Goncalves CR, Fuller R, Oliveira SA, Ishida MA, Precioso AR, Bonfa E. Influenza A/H1N1 vaccination of patients with SLE: can antimalarial drugs restore diminished response under immunosuppressive therapy? [Internet]. Rheumatology. 2012 ; 51( 6): 1061-1069.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1093/rheumatology/ker427
Artigo de periodico
Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practice (2011)
Ribeiro, Ana C. M.; Guedes, Lissiane K. N.; Moraes, Julio C. B.; Saad, Carla G. S.; Aikawa, Nadia E.; Calich, Ana Luisa; França, Ivan L. A.; Carvalho, Jozelio F.; Sampaio-Barros, Percival D.; Goncalves, Celio R.; Borba, Eduardo F.; Timenetsky, Maria do Carmo S.; Precioso, Alexander R.; Duarte, Alberto; Bonfa, Eloisa; Laurindo, Ieda M. M.
Source: Annals of the Rheumatic Diseses. Unidades: FM, HU
Subjects: INFLUENZA (IMUNOLOGIA), PRÁTICA PROFISSIONAL, ARTRITE REUMATOIDE (IMUNOLOGIA), VACINAÇÃO (PREVENÇÃO E CONTROLE)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIBEIRO, Ana C. M. et al. Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practice. Annals of the Rheumatic Diseses, v. 70, n. 12, p. 2144-2147, 2011Tradução . . Disponível em: https://doi.org/10.1136/ard.2011.152983. Acesso em: 02 nov. 2024.
APA
Ribeiro, A. C. M., Guedes, L. K. N., Moraes, J. C. B., Saad, C. G. S., Aikawa, N. E., Calich, A. L., et al. (2011). Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practice. Annals of the Rheumatic Diseses, 70( 12), 2144-2147. doi:10.1136/ard.2011.152983
NLM
Ribeiro ACM, Guedes LKN, Moraes JCB, Saad CGS, Aikawa NE, Calich AL, França ILA, Carvalho JF, Sampaio-Barros PD, Goncalves CR, Borba EF, Timenetsky M do CS, Precioso AR, Duarte A, Bonfa E, Laurindo IMM. Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practice [Internet]. Annals of the Rheumatic Diseses. 2011 ; 70( 12): 2144-2147.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1136/ard.2011.152983
Vancouver
Ribeiro ACM, Guedes LKN, Moraes JCB, Saad CGS, Aikawa NE, Calich AL, França ILA, Carvalho JF, Sampaio-Barros PD, Goncalves CR, Borba EF, Timenetsky M do CS, Precioso AR, Duarte A, Bonfa E, Laurindo IMM. Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practice [Internet]. Annals of the Rheumatic Diseses. 2011 ; 70( 12): 2144-2147.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1136/ard.2011.152983
Artigo de periodico
Immunogenicity and safety of the 2009 non-adjuvanted influenza A/H1N1 vaccine in a large cohort of autoimmune rheumatic diseases (2011)
Saad, Carla G. S.; Borba, Eduardo F.; Aikawa, Nadia E.; Silva, Clovis A.; Pereira, Rosa M. R.; Calich, Ana Luisa; Moraes, Julio C. B.; Ribeiro, Ana C. M.; Viana, Vilma S. T.; Pasoto, Sandra G.; Carvalho, Jozelio F.; França, Ivan L. A.; Guedes, Lissiane K. N.; Shinjo, Samuel K.; Sampaio-Barros, Percival D.; Caleiro, Maria T.; Goncalves, Celio R.; Fuller, Ricardo; Levy-Neto, Mauricio; Timenetsky, Maria do Carmo S.; Precioso, Alexander R.; Bonfa, Eloisa
Source: Annals of the Rheumatic Diseses. Unidade: FM
Subjects: DOENÇAS REUMÁTICAS (IMUNOLOGIA), VACINAS VIRAIS (IMUNOLOGIA), INFLUENZA (IMUNOLOGIA), DOENÇAS NEUROMUSCULARES, IMUNOLOGIA CLÍNICA, AUTOIMUNIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SAAD, Carla G. S. et al. Immunogenicity and safety of the 2009 non-adjuvanted influenza A/H1N1 vaccine in a large cohort of autoimmune rheumatic diseases. Annals of the Rheumatic Diseses, v. 70, n. 7, p. 1068-1073, 2011Tradução . . Disponível em: https://doi.org/10.1136/ard.2011.150250. Acesso em: 02 nov. 2024.
APA
Saad, C. G. S., Borba, E. F., Aikawa, N. E., Silva, C. A., Pereira, R. M. R., Calich, A. L., et al. (2011). Immunogenicity and safety of the 2009 non-adjuvanted influenza A/H1N1 vaccine in a large cohort of autoimmune rheumatic diseases. Annals of the Rheumatic Diseses, 70( 7), 1068-1073. doi:10.1136/ard.2011.150250
NLM
Saad CGS, Borba EF, Aikawa NE, Silva CA, Pereira RMR, Calich AL, Moraes JCB, Ribeiro ACM, Viana VST, Pasoto SG, Carvalho JF, França ILA, Guedes LKN, Shinjo SK, Sampaio-Barros PD, Caleiro MT, Goncalves CR, Fuller R, Levy-Neto M, Timenetsky M do CS, Precioso AR, Bonfa E. Immunogenicity and safety of the 2009 non-adjuvanted influenza A/H1N1 vaccine in a large cohort of autoimmune rheumatic diseases [Internet]. Annals of the Rheumatic Diseses. 2011 ; 70( 7): 1068-1073.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1136/ard.2011.150250
Vancouver
Saad CGS, Borba EF, Aikawa NE, Silva CA, Pereira RMR, Calich AL, Moraes JCB, Ribeiro ACM, Viana VST, Pasoto SG, Carvalho JF, França ILA, Guedes LKN, Shinjo SK, Sampaio-Barros PD, Caleiro MT, Goncalves CR, Fuller R, Levy-Neto M, Timenetsky M do CS, Precioso AR, Bonfa E. Immunogenicity and safety of the 2009 non-adjuvanted influenza A/H1N1 vaccine in a large cohort of autoimmune rheumatic diseases [Internet]. Annals of the Rheumatic Diseses. 2011 ; 70( 7): 1068-1073.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1136/ard.2011.150250

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Source title

Indexado em